183 related articles for article (PubMed ID: 1355733)
1. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
Berridge TL; Doxey JC; Roach AG; Smith CF
Eur J Pharmacol; 1992 Mar; 213(2):205-12. PubMed ID: 1355733
[TBL] [Abstract][Full Text] [Related]
2. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
3. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ
Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719
[TBL] [Abstract][Full Text] [Related]
5. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
John GW; Doxey JC; Walter DS; Reid JL
Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
[TBL] [Abstract][Full Text] [Related]
6. Effects of the imidazoline ligands efaroxan and KU14R on blood glucose homeostasis in the mouse.
Mayer G; Taberner PV
Eur J Pharmacol; 2002 Nov; 454(1):95-102. PubMed ID: 12409010
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats.
Berridge TL; Doxey JC; Roach AG
Eur J Pharmacol; 1992 Mar; 213(2):213-8. PubMed ID: 1355734
[TBL] [Abstract][Full Text] [Related]
8. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
Doxey JC; Roach AG; Samuel J
Clin Sci (Lond); 1985; 68 Suppl 10():155s-159s. PubMed ID: 2857613
[TBL] [Abstract][Full Text] [Related]
9. Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin release.
John GW; Doxey JC; Walter DS; Reid JL
Eur J Pharmacol; 1990 Oct; 187(3):531-6. PubMed ID: 1981556
[TBL] [Abstract][Full Text] [Related]
10. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
Abdel-Zaher AO; Ahmed IT; El-Koussi AD
Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the alpha-adrenoceptors mediating positive inotropy of rat left atria by use of selective agonists and antagonists.
Williamson KL; Broadley KJ
Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):181-98. PubMed ID: 2883945
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
Doxey JC; Lane AC; Roach AG; Virdee NK
Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
[TBL] [Abstract][Full Text] [Related]
13. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
Virtanen R; Savola JM; Saano V
Arch Int Pharmacodyn Ther; 1989; 297():190-204. PubMed ID: 2567152
[TBL] [Abstract][Full Text] [Related]
14. Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.
Bültmann R; von Kügelgen I; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):623-32. PubMed ID: 1682818
[TBL] [Abstract][Full Text] [Related]
15. Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors.
Honda K; Takenaka T; Miyata-Osawa A; Terai M; Shiono K
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):264-72. PubMed ID: 2858821
[TBL] [Abstract][Full Text] [Related]
16. Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
Trendelenburg AU; Wahl CA; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):245-9. PubMed ID: 8692278
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
[TBL] [Abstract][Full Text] [Related]
18. Rilmenidine reveals differences in the pharmacological characteristics of prejunctional alpha2-adrenoceptors in the guinea-pig, rat and pig.
Ali A; Cheng HY; Ting KN; Wilson VG
Br J Pharmacol; 1998 Sep; 125(1):127-35. PubMed ID: 9776352
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
20. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Olmos G; Kulkarni RN; Haque M; MacDermot J
Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
